CureSign
Medical device company developing advanced sensor technology for oncology treatment.
About
CureSign is a medical device company developing a solution to personalize cancer treatment for oncologists. Their technology integrates advanced sensors with signal processing and big data tools to enable patient-specific treatment plans. This product, currently in advanced development, has shown success in preclinical studies and is being prepared for commercial use in oncology preclinical trials.
Technology stack
detected 2026-05-24Est. monthly stack spend~$80/mo
CDN
Cloudflare
Email
Google Workspace
Stack
Tailwind CSS
WordPress
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does CureSign do?
CureSign is a medical device company developing a solution to personalize cancer treatment for oncologists. Their technology integrates advanced sensors with signal processing and big data tools to enable patient-specific treatment plans. This product, currently in advanced development, has shown success in preclinical studies and is being prepared for commercial use in oncology preclinical trials.
When was CureSign founded?
CureSign was founded in 2016.
What industry does CureSign operate in?
CureSign operates in Healthcare, Sensor, Clinical, Oncology, MedTech, HealthTech.
How many employees does CureSign have?
CureSign has approximately 4 people on record.
What is CureSign's current status?
CureSign's current operating status is: Inactive.